Entity Information
- Legal Entity Identifier (LEI)
- 52990091QOK2WBQB9Q20
- Registration ID
- CHE270837659(ID: RA000549)
- Legal Form
- MVII
- Jurisdiction
Switzerland- Legal address country
- Switzerland
Entity Names
Legal Name
AMAL THERAPEUTICS SA(Language: de)
Addresses
Legal Address
Loading map...
Headquarters Address
Loading map...
Additional Information
Entity Status
Current Status
ACTIVENeed to maintain compliance?
LEIs must be renewed annually to keep your entity's information up to date
Renew this LEIReference Guide
LEI status meaning
This LEI is issued, which usually means the registration is active and suitable for current reference and compliance checks.
Renewal date
The next renewal date is August 27, 2027. This is the key deadline for keeping the LEI record current.
Jurisdiction
AMAL THERAPEUTICS SA is registered under jurisdiction CH. Match that jurisdiction with the legal address and local registration number before relying on the LEI.
Parent and ultimate parent
Direct parent is linked to LEI 529900P5FAANZASUYL28, with relationship status active. Ultimate parent is linked to LEI 529900P5FAANZASUYL28, with relationship status active.
How to verify this entity
- •Match the legal name "AMAL THERAPEUTICS SA" to the entity you expect.
- •Check local registration number CHE270837659 against authority RA000549.
- •Confirm the validation source RA000549 and reference CHE270837659.
Related links
- Sibling entity: Boehringer Ingelheim Animal Health Japan Holding GmbH
- Sibling entity: T3 Pharmaceuticals AG
- Sibling entity: Boehringer Ingelheim Venture Fund Asia Limited
- Sibling entity: Boehringer Ingelheim Promeco S.A. de C.V.
- Direct parent: C.H. Boehringer Sohn AG & Co. KG
- Validate a single LEI
- Check multiple LEIs
- Compare statuses and jurisdictions
LEI Verified Badge
Display your verified LEI status on your website with our free badge widget
Get Your Badge Code
Click "Show Code" to view the HTML code for your LEI Verified badge
Entity & LEI Status Summary
This Legal Entity Identifier (LEI) record pertains to AMAL THERAPEUTICS SA, identified by the LEI 52990091QOK2WBQB9Q20. The entity is formally registered under the jurisdiction of Switzerland (via RA000549, registered as CHE270837659) and lists its legal address country as Switzerland. It operates under the legal structure defined as "MVII", classified under the category "GENERAL".
The current operational status of the entity is reported as "ACTIVE". The LEI registration itself is currently "ISSUED", managed by the Local Operating Unit (LOU) 5299000J2N45DDNE4Y28. Key dates associated with this registration include its initial establishment on Aug 27, 2024, its most recent update on Jul 3, 2026, and a scheduled renewal date of Aug 27, 2027.
Maintaining an active and up-to-date LEI is crucial for AMAL THERAPEUTICS SA to ensure continuous participation in global financial markets and regulatory reporting. The corroboration level for this record is "FULLY_CORROBORATED", indicating the extent to which the information has been verified against official registers. The primary validation of this information was performed by RA000549 (as CHE270837659).
Registration Details
Timeline
- Initial Registration
- Aug 27, 2024
- Last Updated
- Jul 3, 2026
- Next Renewal
- Aug 27, 2027
Validation
Primary Validation
- Authority ID
- RA000549
- Registration Number
- CHE270837659
Status Information
Managing Authority
Corporate Structure
Direct Parent
Parent Entity
LEI: 529900P5FAANZASUYL28
Ultimate Parent
Ultimate Parent Entity
LEI: 529900P5FAANZASUYL28
Corporate Structure Visualization
Relationship overview showing parent, sibling, and child entities linked to this LEI.
Child Entities
No child entities found